Harbin Pharmaceutical Group won a controlling stake in CITIC

 Harbin Pharmaceutical Source Group and other companies to win the competition, has made a controlling stake in Harbin Pharmaceutical Group.
Liu, chairman of the original deposit weeks Hayao first time yesterday, said the reason he resigned is because different CITIC Group and its business philosophy.
CITIC into The master Hayao
White Harbin Pharmaceutical Group, CITIC Group, with Warburg in Hong Kong, Carlyle and Heilongjiang Electric Power Investment Corporation and other strategic partners, currently holds a total of 55% of the shares of Harbin Pharmaceutical.
November 2, Hayao announcement that Chairman LIU Cun week submitted his resignation due to retirement reasons; Board agreed that the application and decided to take over by the vice chairman Hao Weizhe.
. . When it comes to China Pharmaceutical Enterprise Management Association
who introduced in 2001, Harbin Pharmaceutical Group of the introduction of strategic investors. Hayao time and reached a preliminary agreement Huayuan: Huayuan assets of 5 billion yuan and 5 billion yuan in cash in exchange for Hayao 47 % of the shares.
However, the agreement of opposition by local SASAC. authorities said that the leadership in the negotiations of individual corruption may exist, this program will result in loss of state assets. because of the net assets at the initial Hayao OK 9.7 billion. This makes the issue re-grounding of the past two years.
end of last year, Hayao again, and CITIC, Dongsheng, China Pharmaceutical Group, to discuss restructuring. was kept Week Liu said: level, must be used after the reorganization of Harbin Pharmaceutical brand management team must be to integrate the enterprise of Harbin Pharmaceutical. br> Hayao, Head of Asset Management, said the reorganization of the right to speak lies in the hands of the SAC, as is the state-owned enterprises Harbin Pharmaceutical.

Hayao which experts cautious on the restructuring is expected to very high : I hope that through the restructuring of the group's output in 2005 is expected to reach 13 billion yuan, profits of 1.8 billion, China's pharmaceutical carrier.
but industry wary of the reorganization. LIU Cun-week less than a week after the resignation from the Harbin Pharmaceutical to 9 received the invitation of well-known pharmaceutical companies, this week from the left side reflects the existence of Harbin Pharmaceutical Liu loss of the latter.
schools administered by the Institute of the Beijing Aerospace PhD student Li Yanping said: partners. taking into account the existence Week Liu top pharmaceutical industry figures, the local government's decision there is a certain risk. Harbin Pharmaceutical's expectations so that made it difficult to determine whether we can achieve. Hayao years, recognition and face the future risk of Harbin Pharmaceutical.